High-throughput screening for Hsp90 ATPase inhibitors
Authors:
- M. Kyle HaddenMHM. Kyle Hadden
- Zeqiang MaZMZeqiang Ma
- Boris A. KornilayevBKBoris A. Kornilayev
- Qi-Zhuang YeQYQi-Zhuang Ye
- Brian S.J. BlaggBBBrian S.J. Blagg
- 1 June 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (11) , 3005-3008
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Hsp90: the vulnerable chaperoneDrug Discovery Today, 2004
- Inhibition of Hsp90: a new strategy for inhibiting protein kinasesBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2004
- Altered states: selectively drugging the Hsp90 cancer chaperoneTrends in Molecular Medicine, 2004
- The Hsp90 chaperone complex as a novel target for cancer therapyAnnals of Oncology, 2003
- Heat-shock protein 90, a chaperone for folding and regulationCellular and Molecular Life Sciences, 2002
- Hsp90 inhibitors as novel cancer chemotherapeutic agentsTrends in Molecular Medicine, 2002
- Hsp90: Chaperoning signal transductionJournal of Cellular Physiology, 2001
- New agents in cancer clinical trialsOncogene, 2000
- The 90-kDa Molecular Chaperone FamilyPharmacology & Therapeutics, 1998
- Cyclophilin 40 (CyP-40), Mapping of Its hsp90 Binding Domain and Evidence That FKBP52 Competes with CyP-40 for hsp90 BindingJournal of Biological Chemistry, 1996